Rani Therapeutics (RANI) - 2024 Q1 - Quarterly Report

WASHINGTON, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission File Number: 001-40672 RANI THERAPEUTICS HOLDINGS, INC. FORM 10-Q (Exact Name of Registrant as Specified in its Charter) | Delaware | 86-3114789 | | --- | --- | | (State or other jurisdiction of incorporation or organizatio ...